Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy

Nat Rev Clin Oncol. 2020 Jun;17(6):332-334. doi: 10.1038/s41571-020-0375-1.

Abstract

Radiotherapy can be safely delivered during the coronavirus disease 2019 (COVID-19) pandemic, often through use of hypofractionated regimens, which minimize the number of visits to treatment centres while also avoiding potentially detrimental delays in the delivery of cancer care.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Breast Neoplasms / complications
  • Breast Neoplasms / radiotherapy*
  • Breast Neoplasms / virology
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / radiotherapy*
  • Coronavirus Infections / virology
  • Disease-Free Survival
  • Female
  • Head and Neck Neoplasms / complications
  • Head and Neck Neoplasms / radiotherapy*
  • Head and Neck Neoplasms / virology
  • Humans
  • Lung Neoplasms / complications
  • Lung Neoplasms / radiotherapy*
  • Lung Neoplasms / virology
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / radiotherapy*
  • Pneumonia, Viral / virology